Isotrix 40SR Tablet contains Isoxsuprine 40mg as its active ingredient, a selective beta-2 adrenergic receptor agonist primarily used as a vasodilator and smooth muscle relaxant. It is indicated for the management of peripheral vascular disorders such as Raynaud’s phenomenon, Buerger’s disease, and other conditions characterized by poor blood circulation. Isoxsuprine facilitates vasodilation by relaxing the smooth muscles of blood vessels, thereby improving blood flow and reducing symptoms like pain, numbness, and cold extremities. The sustained-release formulation ensures a prolonged therapeutic effect, allowing for convenient dosing and improved patient compliance. Isotrix 40SR is typically administered orally, with dosage tailored according to the severity of the condition and patient response. Common adverse effects may include headache, dizziness, flushing, and tachycardia, necessitating caution in patients with cardiovascular disorders. It is contraindicated in individuals with hypersensitivity to Isoxsuprine, severe hypotension, and certain cardiac arrhythmias. Careful monitoring is advised during therapy, especially in pregnant or lactating women, as safety data are limited. Isotrix 40SR should be used under medical supervision, with attention to potential drug interactions and contraindications to ensure optimal therapeutic outcomes.